Hella L. Aberson

608 total citations
15 papers, 481 citations indexed

About

Hella L. Aberson is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Hella L. Aberson has authored 15 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Hella L. Aberson's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Epigenetics and DNA Methylation (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Hella L. Aberson is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Epigenetics and DNA Methylation (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Hella L. Aberson collaborates with scholars based in Netherlands, United States and Indonesia. Hella L. Aberson's co-authors include C. Arnold Spek, Karla Queiroz, Maikel P. Peppelenbosch, Carmen V. Ferreira, Gwenny M. Fuhler, Roberta R. Ruela-de-Sousa, JanWillem Duitman, Maarten F. Bijlsma, Karly Hamulyák and Sarah T.B.G. Loubele and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Hella L. Aberson

15 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hella L. Aberson Netherlands	10	234	144	118	118	65	15	481
Victor Ng United States	9	158 0.7×	72 0.5×	82 0.7×	61 0.5×	65 1.0×	17	393
Amleto Fiocchi Italy	7	83 0.4×	52 0.4×	158 1.3×	220 1.9×	64 1.0×	7	630
Ewa Kurzejamska Sweden	9	176 0.8×	43 0.3×	106 0.9×	66 0.6×	104 1.6×	15	390
Philipp Burkard Germany	7	103 0.4×	75 0.5×	99 0.8×	92 0.8×	37 0.6×	13	310
Alan Koterba United States	12	120 0.5×	51 0.4×	75 0.6×	91 0.8×	25 0.4×	21	386
John E. Lund United States	9	83 0.4×	168 1.2×	48 0.4×	84 0.7×	124 1.9×	14	430
Masami Niiya Japan	10	94 0.4×	148 1.0×	57 0.5×	191 1.6×	33 0.5×	20	377
R. Standring United Kingdom	10	126 0.5×	90 0.6×	36 0.3×	87 0.7×	92 1.4×	27	483
Pietro Delfino Italy	12	180 0.8×	44 0.3×	112 0.9×	71 0.6×	63 1.0×	17	378
Astrid Olsnes Kittang Norway	16	278 1.2×	530 3.7×	141 1.2×	240 2.0×	64 1.0×	30	790

Countries citing papers authored by Hella L. Aberson

Since Specialization

Citations

This map shows the geographic impact of Hella L. Aberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hella L. Aberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hella L. Aberson more than expected).

Fields of papers citing papers by Hella L. Aberson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hella L. Aberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hella L. Aberson. The network helps show where Hella L. Aberson may publish in the future.

Co-authorship network of co-authors of Hella L. Aberson

This figure shows the co-authorship network connecting the top 25 collaborators of Hella L. Aberson. A scholar is included among the top collaborators of Hella L. Aberson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hella L. Aberson. Hella L. Aberson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Aberson, Hella L., Jan Köster, Danny A. Zwijnenburg, et al.. (2024). Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer. International Journal of Molecular Sciences. 25(17). 9449–9449. 1 indexed citations

Boers, L.S., Justin de Brabander, Robert F. J. Kullberg, et al.. (2023). The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(1). L7–L18. 4 indexed citations

Spek, C. Arnold, Hella L. Aberson, & JanWillem Duitman. (2022). Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner. Biomedicines. 10(2). 219–219. 9 indexed citations

Spek, C. Arnold, Hella L. Aberson, Joe M. Butler, Alex F. de Vos, & JanWillem Duitman. (2021). CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs. Cells. 10(9). 2233–2233. 19 indexed citations

Aberson, Hella L., Cynthia Waasdorp, Gerrit K. Hooijer, et al.. (2020). Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cellular Oncology. 43(6). 1161–1174. 45 indexed citations

Aberson, Hella L., et al.. (2020). Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion. BMC Cancer. 20(1). 1183–1183. 28 indexed citations

Duitman, JanWillem, Hella L. Aberson, Kan Chen, et al.. (2020). CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells. Cancers. 12(9). 2546–2546. 13 indexed citations

Queiroz, Karla, Kun Shi, JanWillem Duitman, et al.. (2014). Protease‐activated receptor‐1 drives pancreatic cancer progression and chemoresistance. International Journal of Cancer. 135(10). 2294–2304. 61 indexed citations

Queiroz, Karla, Cornelis van’t Veer, JanWillem Duitman, et al.. (2011). Tissue Factor-Dependent Chemokine Production Aggravates Experimental Colitis. Molecular Medicine. 17(9-10). 1119–1126. 9 indexed citations

10.

Queiroz, Karla, Roberta R. Ruela-de-Sousa, Gwenny M. Fuhler, et al.. (2010). Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene. 29(48). 6314–6322. 123 indexed citations

11.

Borensztajn, Keren, Hella L. Aberson, A.P. de Groot, Maikel P. Peppelenbosch, & C. Arnold Spek. (2009). A mechanism for thrombin‐dependent lung metastasis in patients with osteosarcoma. British Journal of Haematology. 145(4). 548–550. 4 indexed citations

12.

Borensztajn, Keren, Hella L. Aberson, Maikel P. Peppelenbosch, & C. Arnold Spek. (2009). FXa-induced intracellular signaling links coagulation to neoangiogenesis: Potential implications for fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793(5). 798–805. 12 indexed citations

13.

Loubele, Sarah T.B.G., C. Arnold Spek, Peter Leenders, et al.. (2009). Activated Protein C Protects Against Myocardial Ischemia/ Reperfusion Injury via Inhibition of Apoptosis and Inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 29(7). 1087–1092. 68 indexed citations

14.

Loubele, Sarah T.B.G., C. Arnold Spek, Peter Leenders, et al.. (2008). Active site inhibited factor VIIa attenuates myocardial ischemia/reperfusion injury in mice. Journal of Thrombosis and Haemostasis. 7(2). 290–298. 31 indexed citations

15.

Spek, C. Arnold, Annelies Verbon, Hella L. Aberson, et al.. (2003). Treatment with an Anti-CD14 Monoclonal Antibody Delays and Inhibits Lipopolysaccharide-Induced Gene Expression in Humans in Vivo. Journal of Clinical Immunology. 23(2). 132–140. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact